Literature DB >> 28759895

Assessing acceptability and feasibility of provider-initiated HIV testing and counseling in Ghana.

Zachary Tabb1, Kathleen Moriarty1, Madeleine W Schrier2, Ebenezer Amekah3, Timothy P Flanigan4, Margaret Lartey5.   

Abstract

t In Ghana, HIV voluntary counseling and testing remains poorly utilized. The World Health Organization (WHO) has recommended opt-out, provider-initiated testing and counseling (PITC) in order to increase utilization and earlier intervention. Yet implementation challenges remain in resource-scarce settings. This study sought to better understand the dynamics of providing PITC at Apam Catholic Hospital, a district referral hospital in Ghana. Semi-structured interviews were conducted with healthcare providers and patients exploring attitudes regarding PITC, community stigma, and HIV knowledge. Results showed healthcare providers believed PITC would lead to earlier diagnosis and intervention, but concerns persisted over increased costs. Patients welcomed PITC, but expressed discomfort in opting-out. Patients demonstrated incomplete HIV knowledge and widely believed spiritual healers and prayer can cure the infection. Acceptance of PITC by both healthcare providers and patients remains high, but concerns over resource costs and HIV knowledge persist as challenges. [Full article available at http://rimed.org/rimedicaljournal-2017-08.asp].

Entities:  

Keywords:  HIV knowledge; opt-out testing; provider-initiated testing and counseling; resource-scarce

Mesh:

Year:  2017        PMID: 28759895

Source DB:  PubMed          Journal:  R I Med J (2013)        ISSN: 0363-7913


  1 in total

1.  Use of Trained Non-Medical Staff to Improve Access to HIV Testing Services in Africa: Implementation of the World Health Organization Opt-out Approach in Cameroon.

Authors:  Charles Kouanfack; Skinner Nguefack Lekelem; Fala Bede; Claude Ngwayu Nkfusai; Yvette Micha Nouafo; Christian Tchokonte; Nicaise Tsomo Zephirin; Pierre Joseph Fouda
Journal:  Int J MCH AIDS       Date:  2021-04-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.